221 related articles for article (PubMed ID: 22554253)
1. Preventive immunization of aged and juvenile non-human primates to β-amyloid.
Kofler J; Lopresti B; Janssen C; Trichel AM; Masliah E; Finn OJ; Salter RD; Murdoch GH; Mathis CA; Wiley CA
J Neuroinflammation; 2012 May; 9():84. PubMed ID: 22554253
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of a DNA Aβ42 vaccine in adult rhesus monkeys (Macaca mulatta): antibody kinetics and immune profile after intradermal immunization with full-length DNA Aβ42 trimer.
Lambracht-Washington D; Fu M; Frost P; Rosenberg RN
Alzheimers Res Ther; 2017 Apr; 9(1):30. PubMed ID: 28441965
[TBL] [Abstract][Full Text] [Related]
3. Strikingly reduced amyloid burden and improved behavioral performance in Alzheimer's disease mice immunized with recombinant chimeric vaccines by hexavalent foldable Aβ₁₋₁₅ fused to toxin-derived carrier proteins.
Yu YZ; Wang WB; Chen A; Chang Q; Liu S; Zhao M; Wang S; Qiu WY; Pang XB; Xu Q; Sun ZW
J Alzheimers Dis; 2014; 41(1):243-60. PubMed ID: 24625800
[TBL] [Abstract][Full Text] [Related]
4. Maternal antibodies facilitate Amyloid-β clearance by activating Fc-receptor-Syk-mediated phagocytosis.
Illouz T; Nicola R; Ben-Shushan L; Madar R; Biragyn A; Okun E
Commun Biol; 2021 Mar; 4(1):329. PubMed ID: 33712740
[TBL] [Abstract][Full Text] [Related]
5. Prototype Alzheimer's disease vaccine using the immunodominant B cell epitope from beta-amyloid and promiscuous T cell epitope pan HLA DR-binding peptide.
Agadjanyan MG; Ghochikyan A; Petrushina I; Vasilevko V; Movsesyan N; Mkrtichyan M; Saing T; Cribbs DH
J Immunol; 2005 Feb; 174(3):1580-6. PubMed ID: 15661919
[TBL] [Abstract][Full Text] [Related]
6. Active full-length DNA Aβ
Rosenberg RN; Fu M; Lambracht-Washington D
Alzheimers Res Ther; 2018 Nov; 10(1):115. PubMed ID: 30454039
[TBL] [Abstract][Full Text] [Related]
7. Active immunization with the peptide epitope vaccine Aβ3-10-KLH induces a Th2-polarized anti-Aβ antibody response and decreases amyloid plaques in APP/PS1 transgenic mice.
Ding L; Meng Y; Zhang HY; Yin WC; Yan Y; Cao YP
Neurosci Lett; 2016 Nov; 634():1-6. PubMed ID: 27693663
[TBL] [Abstract][Full Text] [Related]
8. Alzheimer's disease abeta vaccine reduces central nervous system abeta levels in a non-human primate, the Caribbean vervet.
Lemere CA; Beierschmitt A; Iglesias M; Spooner ET; Bloom JK; Leverone JF; Zheng JB; Seabrook TJ; Louard D; Li D; Selkoe DJ; Palmour RM; Ervin FR
Am J Pathol; 2004 Jul; 165(1):283-97. PubMed ID: 15215183
[TBL] [Abstract][Full Text] [Related]
9. Antibody response and plasma Abeta1-40 levels in young Microcebus murinus primates immunized with Abeta1-42 and its derivatives.
Trouche SG; Asuni A; Rouland S; Wisniewski T; Frangione B; Verdier JM; Sigurdsson EM; Mestre-Francés N
Vaccine; 2009 Feb; 27(7):957-64. PubMed ID: 19114076
[TBL] [Abstract][Full Text] [Related]
10. Therapeutic versus neuroinflammatory effects of passive immunization is dependent on Aβ/amyloid burden in a transgenic mouse model of Alzheimer's disease.
Minami SS; Sidahmed E; Aid S; Shimoji M; Niikura T; Mocchetti I; Rebeck GW; Prendergast JS; Dealwis C; Wetzel R; Bosetti F; Matsuoka Y; Hoe HS; Turner RS
J Neuroinflammation; 2010 Sep; 7():57. PubMed ID: 20920207
[TBL] [Abstract][Full Text] [Related]
11. Immunization with fibrillar Abeta(1-42) in young and aged canines: Antibody generation and characteristics, and effects on CSF and brain Abeta.
Head E; Barrett EG; Murphy MP; Das P; Nistor M; Sarsoza F; Glabe CC; Kayed R; Milton S; Vasilevko V; Milgram NW; Agadjanyan MG; Cribbs DH; Cotman CW
Vaccine; 2006 Apr; 24(15):2824-34. PubMed ID: 16460841
[TBL] [Abstract][Full Text] [Related]
12. Enhancing Th2 immune responses against amyloid protein by a DNA prime-adenovirus boost regimen for Alzheimer's disease.
Kim HD; Jin JJ; Maxwell JA; Fukuchi K
Immunol Lett; 2007 Sep; 112(1):30-8. PubMed ID: 17686533
[TBL] [Abstract][Full Text] [Related]
13. Immunogenic properties of amyloid beta oligomers.
Dalgediene I; Lasickiene R; Budvytyte R; Valincius G; Morkuniene R; Borutaite V; Zvirbliene A
J Biomed Sci; 2013 Feb; 20(1):10. PubMed ID: 23432787
[TBL] [Abstract][Full Text] [Related]
14. Downregulated apoptosis and autophagy after anti-Aβ immunotherapy in Alzheimer's disease.
Paquet C; Nicoll JA; Love S; Mouton-Liger F; Holmes C; Hugon J; Boche D
Brain Pathol; 2018 Sep; 28(5):603-610. PubMed ID: 29027727
[TBL] [Abstract][Full Text] [Related]
15. An Oral Aβ Vaccine Using a Recombinant Adeno-Associated Virus Vector in Aged Monkeys: Reduction in Plaque Amyloid and Increase in Aβ Oligomers.
Hara H; Ono F; Nakamura S; Matsumoto SE; Jin H; Hattori N; Tabira T
J Alzheimers Dis; 2016 Oct; 54(3):1047-1059. PubMed ID: 27567868
[TBL] [Abstract][Full Text] [Related]
16. Lack of P-glycoprotein Results in Impairment of Removal of Beta-Amyloid and Increased Intraparenchymal Cerebral Amyloid Angiopathy after Active Immunization in a Transgenic Mouse Model of Alzheimer's Disease.
Bruckmann S; Brenn A; Grube M; Niedrig K; Holtfreter S; von Bohlen und Halbach O; Groschup M; Keller M; Vogelgesang S
Curr Alzheimer Res; 2017; 14(6):656-667. PubMed ID: 27915995
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of a DNA Aβ42 Vaccine in Aged NZW Rabbits: Antibody Kinetics and Immune Profile after Intradermal Immunization with Full-Length DNA Aβ42 Trimer.
Lambracht-Washington D; Fu M; Wight-Carter M; Riegel M; Rosenberg RN
J Alzheimers Dis; 2017; 57(1):97-112. PubMed ID: 28222511
[TBL] [Abstract][Full Text] [Related]
18. Active immunization with amyloid-beta 1-42 impairs memory performance through TLR2/4-dependent activation of the innate immune system.
Vollmar P; Kullmann JS; Thilo B; Claussen MC; Rothhammer V; Jacobi H; Sellner J; Nessler S; Korn T; Hemmer B
J Immunol; 2010 Nov; 185(10):6338-47. PubMed ID: 20943998
[TBL] [Abstract][Full Text] [Related]
19. Increased T cell recruitment to the CNS after amyloid beta 1-42 immunization in Alzheimer's mice overproducing transforming growth factor-beta 1.
Buckwalter MS; Coleman BS; Buttini M; Barbour R; Schenk D; Games D; Seubert P; Wyss-Coray T
J Neurosci; 2006 Nov; 26(44):11437-41. PubMed ID: 17079673
[TBL] [Abstract][Full Text] [Related]
20. Consequence of Abeta immunization on the vasculature of human Alzheimer's disease brain.
Boche D; Zotova E; Weller RO; Love S; Neal JW; Pickering RM; Wilkinson D; Holmes C; Nicoll JA
Brain; 2008 Dec; 131(Pt 12):3299-310. PubMed ID: 18953056
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
